Your Article Summary
See Latest ArticlesA Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma
Clinical Cancer Research, 09/05/08
Raz DJ et al. - This multigene assay predicts overall and disease-free survival significantly better than clinical stage and tumor size in patients with early stage lung adenocarcinoma and performs especially well in patients with stage I disease. Prospective clinical trials are needed to determine whether high-risk patients with stage I disease benefit from adjuvant chemotherapy.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09
Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
JACC - Journal of the American College of Cardiology, 12/04/09
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09